A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 in advanced esophageal cancer patients with normal oral intake
Phase 2
- Conditions
- esophageal cancer
- Registration Number
- JPRN-UMIN000017153
- Lead Sponsor
- Second Department of Surgery, Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients with concurrent other primary cancer requiring treatment (2)Pregnancy, possible pregnancy after delivery or breast feeding (3)Patients requiring systemic administration of steroid (4)Positive HBs antigen (5)Patients requiring flucytosine or phenytoin or warfarine administration (6)Patients for allergy of iodine (7)Patient with allergic response to anticancer drugs (docetaxel, cisplatin, S-1) (8)Severe peripheral nerve disorder (9)Patients with interstitial pneumonia or pulmonary fibrosis (10)Active infection (11)Patients with a history of myocardial infarction or unstable angina pectoris within the previous six months (12)Patients with uncontrolled hypertension or diabetes melitus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method